Allison L Swiecki-Sikora1, Lydia Williams2, Ning Li3

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky Markey Cancer Center, Lexington, KY.

JCO precision oncology
|January 15, 2026
PubMed
概括

多个分子瘤委员会 (MTB) 对癌症患者的顺序下一代测序 (NGS) 的审查显示了生存优势. 这些审查有助于确定可行的发现,并指导治疗,改善结果.